FDA Staff Say Forest Laboratories, Inc. Antibiotic Seems Effective

September 2, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Sept 2 (Reuters) - A proposed Forest Laboratories Inc (FRX.N) antibiotic appeared effective in clinical trials for treating skin infections and pneumonia, U.S. drug reviewers said in documents released on Thursday.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase III

Food and Drug Administration (FDA)